| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Email: |
y.liu@mail.biobiopha.com |
| Products Intro: |
Product Name:IVHD-valtrate
CAS:28325-56-6
Purity:>97.0% Package:5mg Remarks:BBP03523
|
|
| | IVHD-valtrate Basic information |
| Product Name: | IVHD-valtrate | | Synonyms: | IVHD-valtrate;Isovaleroxyhydroxydidrovaltratum;Isovaleroxyhydroxydihydrovaltrate;Valtrate HD;Butanoic acid, 3-methyl-2-(3-methyl-1-oxobutoxy)-, [(1S,2'R,4aR,6S,7aS)-6-(acetyloxy)-4a,5,6,7a-tetrahydro-4a-hydroxy-1-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-4-yl]methyl ester | | CAS: | 28325-56-6 | | MF: | C27H40O11 | | MW: | 540.6 | | EINECS: | | | Product Categories: | | | Mol File: | 28325-56-6.mol |  |
| | IVHD-valtrate Chemical Properties |
| | IVHD-valtrate Usage And Synthesis |
| Biological Activity | IVHD-valtrate is an active Valeriana jatamansi derivative that inhibits human ovarian cancer cells in vitro and in vivo. It induces apoptosis of cancer cells and inhibits ovarian cancer cells from arresting in G2/M phase. It has the potential to be a new chemotherapeutic agent for human ovarian cancer research. | | in vitro | IVHD-valtrate inhibits the growth and proliferation of the A2780 and OVCAR-3 ovarian cancer cell lines in a concentration-dependent manner. IVHD-valtrate results in a relatively low cytotoxicity to immortalized non-tumorigenic human ovarian surface epithelial cells (IOSE-144). | | target | |
| | IVHD-valtrate Preparation Products And Raw materials |
|